You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 120 Factors associated with extended survival for patients with platinum-resistant ovarian cancer (PROC) treated with modified vaccinia oncolytic virotherapy (VOV)

Article metrics

Article menu

Download PDFPDF

E-Poster viewings
19–21 September
Basic – Translational science
IGCS19-0687
120 Factors associated with extended survival for patients with platinum-resistant ovarian cancer (PROC) treated with modified vaccinia oncolytic virotherapy (VOV)
Free

 

Online download statistics by month:

Online download statistics by month: September 2019 to October 2024

AbstractFullPdf
Sep 20192809
Oct 20192106
Nov 2019803
Dec 2019805
Jan 20202005
Feb 20201002
Mar 20202602
Apr 20203201
May 20201901
Jun 20201605
Jul 20201601
Aug 2020602
Sep 20201201
Oct 2020403
Nov 2020801
Dec 2020803
Jan 2021500
Feb 2021001
Mar 20211001
Apr 2021603
May 2021102
Jun 2021102
Jul 2021003
Aug 2021001
Sep 2021005
Oct 20212016
Nov 2021408
Dec 20211601
Jan 20221300
Feb 20221001
Mar 2022200
Apr 2022200
May 20221008
Jun 2022502
Jul 2022800
Aug 20221006
Sep 20221803
Oct 2022404
Nov 2022705
Dec 20221002
Jan 20231002
Feb 2023600
Mar 2023600
Apr 2023903
May 2023400
Jun 20231002
Jul 2023402
Aug 2023302
Sep 2023201
Oct 2023001
Nov 20231001
Dec 20232501
Jan 20243600
Feb 2024802
Mar 202411040
Apr 2024408
May 2024403
Jun 2024801
Jul 20241503
Aug 20242404
Sep 2024701
Oct 2024200
Total5940201